Loading Events

Translational Proof of Concept Award Launch

  • This event has passed.

Arthritis Research UK, the biggest funder of research into the cause, treatment and cure of all forms of arthritis in the UK, and the Medical Technologies Innovation and Knowledge Centre, have joined together to offer funding to progress research ideas with commercial potential.

The Translational Proof of Concept Awards will provide support for one year with funding of £100,000 to accelerate exciting innovations that support the lives of people with musculoskeletal disorders.

Awards will be accepted from scientists and clinicians in UK universities, and will be judged on the clinical need, potential market opportunity and industry confidence to progress and support the technology to market.

The charity has joined forces with the national Medical Technologies Innovation and Knowledge Centre to access expertise in product development, speeding up route to market and reducing the risk of late stage failure.

For more information, please click here. REGISTER HERE.


10.00 Registrations and coffee

10.30 Welcome

10.35 Arthritis Research UK – Fighting the battle against Arthritis, Dr Stephen Simpson, Director of Research, Arthritis Research UK

10.55 Medical Technologies IKC – Innovate faster, develop better technologies, reduce risk, Dr Ceri Williams, Medical Technologies IKC

11.15 Advancing medical technologies for musculoskeletal disorders, Prof Gordon Blunn, UCL

11.35 Arthritis Research UK and Medical Technologies IKC Translational Proof of Concept Award, Dr Mike Raxworthy, University of Leeds

12.05 Q&A, Dr Graeme Howling, Dr Ceri Williams, Dr Mike Raxworthy, Sarah Odoi

12.45 Networking lunch

13.30 1-to-1 surgeries to explore projects: Book a ticket during online registration

15.00 Close




November 21, 2014
10:00 am - 3:00 pm


The Light
Friends House,Euston Road, London,

Cookies on IBME website

Our website uses cookies to provide us with important information about visitors. By continuing to browse the site we'll assume that you are happy to receive all cookies set by IBME.